Bacterial Infections During Pregnancy: What You Need to Know
"A closer look at Atopobium vaginae, subchorionic hematomas, and the potential risks for pregnant women."
Pregnancy is a transformative journey, but it also brings heightened vulnerability to infections. While most expectant mothers are aware of common threats like the flu, bacterial infections can sometimes fly under the radar—despite posing significant risks to both mother and child. Understanding these risks and how to mitigate them is crucial for a healthy pregnancy.
One area of increasing concern is the role of specific bacteria like Atopobium vaginae and their association with complications such as subchorionic hematomas. These hematomas, which are collections of blood between the uterine lining and the gestational sac, can sometimes become infected, leading to more severe health issues. Although infections of this nature are rare, understanding their potential impact is essential for proactive care.
This article explores a recent case study that sheds light on the complexities of bacterial infections during pregnancy, focusing on the identification, treatment, and outcomes associated with Atopobium vaginae and subchorionic hematomas. By diving into the details of this case, we aim to provide valuable insights and practical knowledge for expectant mothers and healthcare providers alike.
Current Evidence and Impact
The available sources do not establish a single current prevalence figure for bacterial infections during pregnancy. They do show that Atopobium vaginae is associated with bacterial vaginosis and preterm delivery, while invasive infection and bacteremia have been rarely reported. One case report describes a first-time mother who developed A. vaginae bacteremia during labor, identified through 16S rRNA gene sequencing. BV-associated bacteria can also appear attached to vaginal epithelial cells known as clue cells.
Diagnosis and Detection
The CDC identifies vaginal Gram stain as the reference standard laboratory method for diagnosing bacterial vaginosis. This method assesses the relative concentrations of lactobacilli, small gram-negative or gram-variable rods such as Gardnerella vaginalis or Bacteroides, and curved gram-negative rods such as Mobiluncus. Research on vaginal communities has also developed organism-specific standards for estimating the bacterial burden of Gardnerella, Prevotella, and Lactobacillus, from an optimal state to a mature polymicrobial BV biofilm. Atopobium vaginae is an important component of abnormal BV flora, although it can also be detected in normal flora and is more common in people with BV.
How Understanding Evolved
Bacterial vaginosis has long been described as a common cause of vaginitis and has been linked with pelvic inflammatory disease, adverse pregnancy outcomes, and increased risk of sexually transmitted infection and HIV acquisition. Earlier work characterized BV as involving the loss of the usual vaginal microbial balance, although its precise etiology remained unclear. More recent literature identifies Atopobium vaginae, now also called Fannyhessea vaginae, as an anaerobic bacterium increasingly implicated in BV and other infections. However, the 2025 overview emphasizes that comprehensive information about its characteristics remains limited.
Understanding the Risks: Atopobium Vaginae and Subchorionic Hematomas
A subchorionic hematoma occurs when blood accumulates between the gestational sac and the uterine wall early in pregnancy. While many of these hematomas resolve on their own, some can lead to complications, especially if they become infected. Infections can arise from various sources, including bacteria commonly found in the vaginal flora.
- Subchorionic hematomas can create an environment conducive to bacterial infections.
- Atopobium vaginae, though normally present, can become problematic when it overgrows or spreads.
- Untreated infections can lead to sepsis, preterm birth, or miscarriage.
What Recent Reviews Show
A September 2024 study reports that anaerobic bacteria, including Gardnerella vaginalis, Megasphaera species, and Atopobium vaginae, are identified more often in bacterial vaginosis than lactobacilli. A 2026 narrative review similarly associates Lactobacillus dominance and low microbial diversity with favorable pregnancy outcomes. That review links greater microbial diversity and the presence of anaerobes such as Gardnerella vaginalis and Atopobium vaginae with increased preterm-birth risk and other complications. Recent case-based work has also isolated multiple A. vaginae strains from patients with vaginal symptoms and oral infections.
Limits of Microbiome-Based Conclusions
The vaginal microbiome can contain several organisms besides Lactobacillus, including Gardnerella vaginalis, Atopobium vaginae, Prevotella species, Sneathia amnii, and Candidatus Lachnocurva vaginae. One source describes BV as a shift in the microbial community rather than an infection in the traditional sense, with protective Lactobacillus species replaced by a diverse anaerobic community. These descriptions caution against treating the detection of a single organism as proof of disease. They also illustrate why associations between microbiome composition and pregnancy outcomes should not automatically be interpreted as proof of causation.
Changes in the Vaginal Community
A clinical review describes a sequence in which BV is first associated with a decrease in Lactobacillus crispatus, followed by increases in Prevotella bivia, Gardnerella vaginalis, Atopobium vaginae, and Megasphaera type 1. The same source reports that the polymicrobial load may be up to 1,000 times higher than in normal vaginal flora. It also characterizes BV as a biofilm-associated condition. These findings contrast with a Lactobacillus-dominant vaginal community and emphasize that BV involves a community-level change rather than only the presence of one bacterium.
Protecting Your Pregnancy: Prevention and Early Intervention
While the case study highlights a rare and complex situation, it underscores the importance of vigilance and proactive care during pregnancy. Expectant mothers can take several steps to minimize their risk of bacterial infections and promote a healthy pregnancy:
Putting the Evidence Together
A cross-sectional study assessed Atopobium vaginae and Gardnerella vaginalis concentrations in pregnant women across age groups, gestational ages, vaginal-flora categories, and HIV status. Its stated objective was to determine which DNA concentrations best distinguished BV-positive from non-BV categories. Separately, a case report describes A. vaginae as an anaerobic gram-positive rod that can be part of vaginal flora and is increasingly associated with BV. The report calls bacteremia a rare outcome and identifies its case as only the third reported case in the literature at that time.
Where Research May Go Next
Future research may clarify how changes in the vaginal microbial community relate to pregnancy outcomes and which findings are clinically meaningful. More work is also needed to distinguish organisms that are present from organisms that are driving disease. Because the available material does not establish validated future interventions or projections, potential advances should be viewed as research questions rather than established care recommendations.
Why These Cases Matter
The case-focused material highlights the complexity of bacterial infections during pregnancy by bringing together identification, treatment, and outcomes involving Atopobium vaginae and subchorionic hematomas. It presents these cases as relevant to both expectant mothers and healthcare providers. The broader challenge is interpreting an uncommon organism and a complicated pregnancy context without assuming that every detected bacterium has the same clinical significance.
The Experience Behind the Diagnosis
Pregnancy-associated bacterial findings can be difficult to interpret when symptoms, laboratory results, and pregnancy complications overlap. The limited source material suggests that real-world care must account for both the individual patient’s circumstances and the uncertainty surrounding uncommon organisms. Clear communication between patients and healthcare providers is therefore important when discussing what a test result may or may not mean. The available sources do not provide enough evidence to quantify the emotional or social effects on patients.